The SAPIEN 3 Ultra RESILIA valve is designed to provide long-term durability and reliable performance for patients undergoing transcatheter aortic valve replacement. Its RESILIA tissue reduces calcification, helping preserve functionality over time. An improved outer skirt reduces paravalvular leak, supporting safer outcomes. The valve maintains dependable coronary access for later interventions. Dry tissue storage simplifies preparation and increases efficiency. Building on the established SAPIEN 3 platform, it offers strong hemodynamics and controlled deployment, giving physicians a predictable, effective solution for treating aortic stenosis in a broad range of clinical situations.